You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CRPC

Showing 26 - 50 of 444
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Boston (Cabozantinib, Abiraterone)

Completed
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 5, 2021

Metastatic Castration-resistant Prostate Cancer Trial in Korea, Republic of, United States (Phase I and Phase II:

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Phase I and Phase II: LAE001/prednisone + afuresertib
  • Tucson, Arizona
  • +16 more
Nov 30, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)

Active, not recruiting
  • Prostate Cancer
  • Castration Resistant Prostate Cancer
  • San Francisco, California
  • +4 more
Mar 18, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston

Completed
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2022

Metastatic Castrate Resistant Prostate Cancer Trial in Boston, Detroit, Columbus (Docetaxel, Radium 223)

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer
  • Boston, Massachusetts
  • +3 more
Feb 22, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Abiraterone Acetate,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Gather More Information About Bone Fractures and Survival in

Completed
  • Metastatic Castration-Resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Other standard care
  • Database Study, Sweden
    Database Study
Jul 1, 2021

CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers

Active, not recruiting
  • Prostate Cancer
  • +3 more
  • blood and FFPE sample collection
  • Ancona, AN, Italy
  • +8 more
Feb 25, 2021

Health-related Quality of Life, Psychological Distress and

Completed
  • Castrate Resistant Prostate Cancer
  • Bone Metastases
  • 's-Hertogenbosch, Netherlands
  • +10 more
Jul 29, 2021

Prostate Cancer Recurrent Trial in Indianapolis (Low protein diet, Control protein diet)

Completed
  • Prostate Cancer Recurrent
  • Low protein diet
  • Control protein diet
  • Indianapolis, Indiana
  • +1 more
Mar 25, 2021

Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Tucson, Arizona
  • +62 more
Jan 18, 2023

Metastatic Castrate-resistant Prostate (CRPC) Cancer Trial in Villejuif (ODM-201, Enzalutamide)

Unknown status
  • Metastatic Castrate-resistant Prostate (CRPC) Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Feb 23, 2021

NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC), NSCLC (NSCLC) Trial (Birabresib)

Terminated
Has Results
  • NUT Midline Carcinoma (NMC)
  • +3 more
  • (no location specified)
Jan 7, 2021

Bone Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Recruiting
  • Bone Metastatic Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Linz, Oberösterreich, Austria
  • +15 more
Aug 24, 2022

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (docetaxel,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 2, 2021

Prostate Cancer Trial in United States (Docetaxel, Enzalutamide, Prednisone)

Terminated
Has Results
  • Prostate Cancer
  • Chicago, Illinois
  • +4 more
Mar 11, 2021

Castrate-resistant Prostate Cancer (CRPC) Trial in United States (tomivosertib (eFT508))

Completed
  • Castrate-resistant Prostate Cancer (CRPC)
  • tomivosertib (eFT508)
  • New Haven, Connecticut
  • +9 more
Apr 27, 2020

Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)

Not yet recruiting
  • Castration Resistant Prostate Cancer
  • Castration Sensitive Prostate Cancer
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 16, 2023

NUT Midline Carcinoma, Triple Negative Breast Cancer, NSCLC With Rearranged ALK Gene/Fusion Protein or KRAS Mutation Trial

Completed
Has Results
  • NUT Midline Carcinoma
  • +5 more
  • (no location specified)
Jan 7, 2021

Castration-resistant Prostate Cancer Trial in Fairfax (Calcitriol, Ketoconazole, Hydrocortisone)

Terminated
Has Results
  • Castration-resistant Prostate Cancer
  • Calcitriol, Ketoconazole, Hydrocortisone
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Jan 19, 2021

Prostate Cancer Trial in Boston, New York (PLX3397)

Terminated
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Feb 18, 2020

Castration-resistant Prostate Cancer Trial in Worldwide (BEZ235, BKM120)

Completed
  • Castration-resistant Prostate Cancer
  • Los Angeles, California
  • +9 more
Dec 6, 2020

Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or

Completed
  • Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
  • Avelumab Phase 1b
  • +3 more
  • Fayetteville, Arkansas
  • +57 more
Jan 18, 2023

Prostate Cancer Trial in United States (carboplatin, RAD 001, prednisone)

Completed
Has Results
  • Prostate Cancer
  • Evanston, Illinois
  • +3 more
Nov 6, 2020